Health

Opinion: 50 years ago, my colleagues and I pursued basic research science that became revolutionary

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 09/10/2026, 08:36:24 UTC.

Briefings

The provided text is a 2026 opinion piece by the author reflecting on the 50th anniversary of a collaborative paper identifying interleukin-2 (IL-2) as a pivotal cytokine for T cell regulation. The article features a perspective by immunologists Rafi Ahmed and Steven Rosenberg, who analyze the discovery's significance. The author notes that the legacy of IL-2 depends on the definition of importance, but the text does not specify the exact nature of this legacy or provide further details on the collaborative work beyond the publication date.

Key points

• The article commemorates the 50th anniversary of a collaborative paper identifying interleukin-2 (IL-2) as a key cytokine essential for T cell growth and regulation.
• Renowned immunologists Rafi Ahmed and Steven Rosenberg provided a perspective on the discovery, prompting the author to consider the specific legacy of IL-2.

Context and limitations

The text is limited to the author's personal reflection and the perspective of two named immunologists. It does not specify the exact nature of IL-2's legacy, the specific collaborative outcomes, or the date of the original paper's publication.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 09/10/2026, 09:25:47 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeibz6agggkpb7nknepfrnbliva54cfdupxknhqk6qqjhl2hqsolm4y